Morgan Stanley downgraded Glanbia (GLAPF) to Equal Weight from Overweight with a price target of EUR 18.20, down from EUR 18.30. The firm says increasing whey input costs could drive concerns over the company’s Performance Nutrition segment volumes and margin.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLAPF:
- Glanbia Cancels Newly Repurchased Shares Under €50m Buy-Back
- Glanbia: Structural Growth Offset by Whey Cost Inflation and Limited Near‑Term Upside (Hold Rating Maintained)
- Glanbia CFO Marks Share Award Vesting and Tax-Related Sale
- Glanbia Updates Share Capital and Total Voting Rights
- Glanbia Advances €50m Share Buyback With Euronext Dublin Purchase